Skip to main content

Piramal progresses two API sites

Piramal Pharma Solutions (PPS) has announced the implementation of “various tools to unlock API manufacturing capacity and support client needs in drug development and on-patent projects” at its 40-hectare site at Digwal in the Indian state of Telangana. This came shortly after its new API plant at Aurora, Ontario, came online.

Charitable appeal – Sabin Metal helping orphans and Ukrainian refugees

Through the Andrew Sabin Family foundation, precious metal recycler Sabin Metal is sponsoring the construction of an orphanage and bomb shelter at the City of Goodness domestic violence centre in Western Ukraine. It has raised $250,000 of the $350,000 goal and is now asking for help to secure the rest.

To date, the centre has taken in more than 60 orphans as well as refugees from across the country. As the number of residents increases, the need for more space and heightened safety is an imperative.

Two zinc chemical firms combined

Private equity firm Aterian Investment Partners has acquired EverZinc and will combine it with existing affiliate US Zinc to make the world’s largest maker of zinc chemical products. This will be based in Houston and will operate under the EverZinc name, with EverZinc CEO Vincent Dujardin becoming CEO and US Zinc president and CEO Joel Hawthorne as vice chairman.

RAC: No change to glyphosate classification

The EU’s Risk Assessment Committee has assessed glyphosate’s hazardous properties against criteria in the Classification, Labelling & Packaging Regulation and concluded that its classification should not be changed. This is consistent with the proposal of the four member states currently assessing the substance and RAC’s own 2017 opinion.

DSM and Firmenich in mega-merger

DSM and Swiss-based flavours and fragrances house Firmenich have agreed to merge. The deal, which is expected to close in 1H 2023, is valued at about $19.6 billion. DSM-Firmenich would have about €11.4 billion/year in sales, comparable to IFF after its combination with DuPont’s Nutrition and Biosciences business early last year.

Subscribe to Current issue